Browsing by Author Gangadharan Komala, Muralikrishna

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2014Empagliflozin for the treatment of Type 2 diabetesGangadharan Komala, Muralikrishna; Mather, Amanda; Northern Clinical School: Kolling Institute; Clinical SchoolsEmpagliflozin for the treatment of Type 2 diabetes, Expert Review of Clinical Pharmacology, vol.7, 3, 2014,pp 271-279
2014Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout MiceGangadharan Komala, Muralikrishna; Gross, Simon; Huang, Chunling; Mather, Amanda; Mudaliar, Harshini; Panchapakesan, Usha; Pegg, Kate; Pollock, Carol; Shen, Sylvie; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Clinical Schools; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: MedicineInhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice, PloS One, vol.9, 11, 2014,pp 1-12
2015Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin.Gangadharan Komala, Muralikrishna; Gross, Simon; Panchapakesan, Usha; Pollock, Carol; Zaky, Amgad; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Kolling InstituteLinagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin., PloS One, vol.10, 10, 2015,pp e0141143-N/A
2016Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetesGangadharan Komala, Muralikrishna; Gross, Simon; Panchapakesan, Usha; Pollock, Carol; Zaky, Amgad A; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Kolling InstituteSaxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes, Nephrology, vol.21, 5, 2016,pp 423-431
2016Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetesGangadharan Komala, Muralikrishna; Gross, Simon; Panchapakesan, Usha; Pollock, Carol; Zaky, Amgad A; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Kolling InstituteSaxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes, Nephrology, vol.21, 5, 2016,pp 423-431
2015Screening for Malignancy after Kidney TransplantSud, Kamal; Gangadharan Komala, Muralikrishna; Nepean Clinical School: MedicineScreening for Malignancy after Kidney Transplant in Malignancy and Kidney Transplant, Elsevier, 2015, pp. 29-43
2013Sodium glucose cotransporter 2 and the diabetic kidneyGangadharan Komala, Muralikrishna; Mather, Amanda; Panchapakesan, Usha; Pollock, Carol; Northern Clinical School: Kolling Institute; Clinical Schools; Northern Clinical School: Medicine; Northern Clinical School: MedicineSodium glucose cotransporter 2 and the diabetic kidney, Current Opinion In Nephrology And Hypertension, vol.22, 1, 2013,pp 113-119